#PFFSummit2019 starts today! We look forward to engaging with the medical professionals, patients and caregivers in San Antonio this week to share data, insights and inspiration in the fight against #IPF.

#Idiopathicpulmonaryfibrosis is a deadly and difficult-to-diagnose disease. Data show that our #Envisia Genomic Classifier complements HRCT and clinical factors to help provide a more confident #IPF diagnosis. #PFFSummit2019

Good news from American Lung Association: The #lungcancer survival rate has increased dramatically over the past 10 years. We’re proud to be part of the community that is working to save more lives through earlier disease detection and diagnosis. #LCAM lung.org/local-content/…

We come to work every day to #ChangeLungCancer detection and diagnosis for thousands of patients and their families. Thanks to LUNGevity Foundation for the opportunity to share what inspires us during #LCAM.

We took time out on Friday to celebrate our major step towards expanding our business internationally. investor.veracyte.com/news-releases/…

We’re excited to announce a biopharmaceutical collaboration with Acerta Pharma and AstraZeneca — which is enabled by our expanding global footprint and #genomic tests in new oncology indications. investor.veracyte.com/news-releases/… #PrecisionMedicine

Data science is increasingly changing how physicians diagnose, manage and treat cancer patients. Want to know what’s happening and what’s next? Tune in to Bonnie Anderson’s fireside chat with Dr. Clifford Hudis, CEO of ASCO, at #PMWC2020 on Friday, Jan. 24, 9 a.m. (Track 3).

Nearly 700-patient study using Prosigna test to identify women with #breastcancer subtypes likely to benefit from aggressive chemotherapy published in Nature Communications. investor.veracyte.com/news-releases/…

Combining the new @YaleOCR 52-gene signature and our #Envisia Genomic Classifier on the nCounter FLEX Analysis System could help doctors improve #IPF diagnose and better personalize treatment for this serious lung disease. Yale School of Medicine bit.ly/VCYTYale

The non-invasive, blood-based #genomic test we’re advancing with @YaleOCR could help inform key treatment decisions for patients with idiopathic pulmonary fibrosis (#IPF). Yale School of Medicine. Learn more bit.ly/VCYTYale

Exciting news! Veracyte, Inc. and Yale PCCSM announced an exclusive licensing agreement to advance the first genomic test for predicting disease progression in patients with idiopathic pulmonary fibrosis. ⬇️ Read more businesswire.com/news/home/2020…

We’re proud to announce the launch of #MoreAboutYou, a new informational resource for patients with #thyroidnodules. Visit AskForAfirma.com to learn more! #endocrinology investor.veracyte.com/news-releases/…

Idiopathic pulmonary fibrosis (#IPF) is a serious and difficult-to-diagnose #lungdisease. Data published in the @ATScommunity journal AJRCCM show our #Envisia Genomic Classifier improves physicians’ ability to diagnose it & other ILDs w/out surgery.businesswire.com/news/home/2020…

Clinical data presented at #ATS2020 this week demonstrate that our #Percepta Genomic Classifier can reduce uncertainty in #lungcancer diagnosis by increasing the ability of a standard diagnostic procedure to detect malignant #lungnodules.

Idiopathic pulmonary fibrosis (#IPF) is a deadly and difficult-to-diagnose #lungdisease. Data presented @ #ATS2020 show our #Envisia Genomic Classifier accurately identifies a hallmark sign of #IPF & more than doubles the sensitivity of a standard diagnostic procedure alone.

#Lungnodule management is challenging in normal times. #COVID19 has made it harder. Wednesday, 9/9 at 6 pm ET, leading pulmonologists will share the latest updates & real-world best practices during a live webinar. Interested clinicians can register here bit.ly/LNMCOVID19

About 200K people in the U.S. and Europe are evaluated for #pulmonaryfibrosis and other interstitial lung diseases each year. Go to pulmonaryfibrosis.org to learn more about this serious lung disease. #PFMonth #ILD #IPF

Join Inflammatix at the 10th Sepsis Update in Weimar, Germany. We will be hosting a lunch symposium on Friday, September 10th, from 12:30 – 13:30. You can also catch us on the showroom floor at booth #30. We look forward to meeting you. bit.ly/3CvFyym #GSS